We found that the five-year overall survival rate in HCC patients with low expression of MAPK10 was significantly reduced compared to patients with high expression of MAPK10 [HR (hazard ratio) = 0.64, log-rank P= 0.037; Figure 1B)]. The gene discussed is MAPK10; the disease is hepatocellular carcinoma.